NIH-funded research R01 grant

How obesity and diabetes affect the immune response to viral infections

Official title: Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses

Funded at New York University School of Medicine · NIH-10999623 · Data updated 2026-11-12

This study is looking at how being overweight and having type 2 diabetes can affect your body's ability to fight off respiratory viruses like COVID-19 and the flu, using mice to learn more about why these conditions might make infections worse, with hopes of finding better treatments for people who are affected.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 15, 2024
Project endJune 30, 2028
Funding year2024
Award (this year)$769,522
NIH project number1R01DK138675-01A1
Project IDNIH-10999623 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with obesity and type 2 diabetes who are at risk for severe respiratory viral infections.

Less likely to help

Patients without obesity or diabetes may not benefit directly from the findings of this research.

What this research studies

This research investigates how obesity and type 2 diabetes influence the body's immune response to respiratory viral infections like SARS-CoV-2 and Influenza. By using mouse models, the study examines the effects of hyperglycemia and obesity on inflammation and anti-viral responses. The researchers aim to understand the mechanisms that lead to increased disease severity and mortality in individuals with these conditions. The findings could help identify potential therapeutic targets to improve immune responses in affected patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients with obesity and diabetes during viral infections.

How similar studies have gone: Previous research has shown that understanding the immune response in similar contexts can lead to significant advancements in treatment strategies.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Khanna, Kamal Mohan — New York University School of Medicine
  • Study coordinator: Khanna, Kamal Mohan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.